| Value | ₹48.00 Cr |
|---|
BSE filing, NSE: SICAGEN. Summary written from the filing by ALFA Finder's alert engine.
Sicagen India Ltd: key numbers
- Share price
- ₹48.70
- Market cap
- ₹192.7 Cr
- Revenue (annual)
- ₹973.5 Cr
- Net profit (annual)
- ₹18.07 Cr
- P/E (TTM)
- 9.4×Sector 45.2×
- Promoter holding
- 61.13%+0.00% QoQ
- FII holding
- 2.47%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sicagen India Ltd
All →Sicagen India Board Meeting Date
Sicagen India will hold a board meeting on 2 November 2026 to approve unaudited results. Trading window stays closed until 48 hours after declaration.
Sicagen India Other Announcement
Sicagen India Ltd has submitted its quarterly shareholding pattern for the quarter ended September 30, 2026, as required by regulatory filings.
Sicagen India Annual General Meeting
Sicagen India Ltd held its 22nd Annual General Meeting on September 17, 2026. The meeting transacted ordinary and special business as per the agenda.
Sicagen India Other Announcement
Sicagen India has issued a notice to physical shareholders requesting mandatory updation of PAN, KYC, and nomination details with the company's RTA, in line with SEBI circulars.
Sicagen India Annual General Meeting
Sicagen India Limited issued a notice for its 22nd Annual General Meeting to be held on September 17, 2026, via video conferencing.
Sicagen India Annual General Meeting
Sicagen India Ltd has scheduled its 22nd Annual General Meeting for September 17, 2026. The meeting will be held via video conferencing to transact ordinary and special business.
- Value
- ₹0.01 Cr
Other credit rating announcements
All →20 Microns Credit Rating
CRISIL reaffirmed 20 Microns' bank loan ratings at A/Stable and A1 on ₹117 crore facilities. Ratings remain unchanged from prior assessment.
Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.